Association Between T2-related Comorbidities and Effectiveness of Biologics in Severe Asthma

Author:

Wechsler Michael E.1,Scelo Ghislaine23,Larenas-Linnemann Désirée E. S.4,Torres-Duque Carlos A.56ORCID,Maspero Jorge7,Tran Trung N.8,Murray Ruth B.3,Martin Neil89,Menzies-Gow Andrew N.1011,Hew Mark1213,Peters Matthew J.14,Gibson Peter G.1516,Christoff George C.17,Popov Todor A.18,Côté Andréanne19,Bergeron Celine20,Dorscheid Delbert21,FitzGerald J. Mark22,Chapman Kenneth R.23,Boulet Louis Philippe24,Bhutani Mohit25,Sadatsafavi Mohsen26,Jiménez-Maldonado Libardo27,Duran-Silva Mauricio27,Rodriguez Bellanid28,Celis-Preciado Carlos Andres2930,Cano-Rosales Diana Jimena28,Solarte Ivan2930,Fernandez-Sanchez Maria Jose2930,Parada-Tovar Patricia5,von Bülow Anna31,Bjerrum Anne Sofie32,Ulrik Charlotte S.33,Assing Karin Dahl34,Rasmussen Linda Makowska35,Hansen Susanne3637,Altraja Alan38,Bourdin Arnaud39,Taille Camille40,Charriot Jeremy39,Roche Nicolas41,Papaioannou Andriana I.42,Kostikas Konstantinos43ORCID,Papadopoulos Nikolaos G.4445,Salvi Sundeep46,Long Deirdre47,Mitchell Patrick D.48,Costello Richard4950,Sirena Concetta51,Cardini Cristina51,Heffler Enrico5253,Puggioni Francesca52,Canonica Giorgio Walter5253,Guida Giuseppe54,Iwanaga Takashi55,Al-Ahmad Mona56,García Ulises57,Kuna Piotr58,Fonseca João A.596061,Al-Lehebi Riyad6263,Koh Mariko S.64,Rhee Chin Kook65ORCID,Cosio Borja G.66ORCID,Perez de Llano Luis67,Perng Diahn-Warng (Steve)6869,Huang Erick Wan-Chun70,Wang Hao-Chien71,Tsai Ming-Ju7273,Mahboub Bassam74,Salameh Laila Ibraheem Jaber7475,Jackson David J.76,Busby John77,Heaney Liam G.78,Pfeffer Paul E.7980,Goddard Amanda Grippen81,Wang Eileen82,Hoyte Flavia C. L.82,Chapman Nicholas M.83,Katial Rohit82,Carter Victoria23,Bulathsinhala Lakmini23,Eleangovan Neva23,Ariti Con23,Lyu Juntao84,Porsbjerg Celeste85,Price David B.2386ORCID

Affiliation:

1. Cohen Family Asthma Institute and Department of Medicine,

2. Observational and Pragmatic Research Institute, Singapore;

3. Optimum Patient Care Global, Cambridge, United Kingdom;

4. Centro de Excelencia en Asma y Alergia, Hospital Médica Sur, Ciudad de México, Mexico;

5. CINEUMO/Centro Internacional de Investigación en Neumología, Respiratory Research Center, Fundación Neumológica Colombiana, Bogotá, Colombia;

6. Universidad de La Sabana, Chia, Colombia;

7. Clinical Research for Allergy and Respiratory Medicine, CIDEA Foundation, Buenos Aires, Argentina;

8. BioPharmaceuticals Medical, AstraZeneca, Gaithersburg, Maryland;

9. University of Leicester, Leicester, United Kingdom;

10. AstraZeneca, Cambridge, United Kingdom;

11. Royal Brompton & Harefield Hospitals, London, United Kingdom;

12. Allergy, Asthma & Clinical Immunology Service, Alfred Health, Melbourne, Victoria, Australia;

13. Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia;

14. Department of Thoracic Medicine, Concord Hospital, Sydney, New South Wales, Australia;

15. Australian Severe Asthma Network, Priority Research Centre for Healthy Lungs, University of Newcastle, Newcastle, New South Wales, Australia;

16. Hunter Medical Research Institute, Department of Respiratory and Sleep Medicine, John Hunter Hospital, New Lambton Heights, New South Wales, Australia;

17. Medical University, Sofia, Bulgaria;

18. University Hospital Sv. Ivan Rilski, Sofia, Bulgaria;

19. Department of Medicine, Laval University, Quebec City, Quebec, Canada;

20. Vancouver General Hospital and University of British Columbia, Vancouver, British Columbia, Canada;

21. Center for Heart Lung Innovation,

22. Department of Medicine, and

23. University of Toronto, Toronto, Ontario, Canada;

24. Québec Heart and Lung Institute, Université Laval, Quebec City, Quebec, Canada;

25. Division of Pulmonary Medicine, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada;

26. Respiratory Evaluation Sciences Program, Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia, Canada;

27. Fundación Neumológica Colombiana, Atención integral y rehabilitación en asma or Comprehensive Care and Rehabilitation in Asthma (ASMAIRE) Programa, Bogotá, Colombia;

28. Instituto Neumológico del Oriente, Bucaramanga, Colombia;

29. Pulmonary Unit, San Ignacio University Hospital, Bogota, Colombia;

30. Faculty of Medicine, Pontificia University Javeriana, Bogota, Colombia;

31. Respiratory Research Unit, Department of Respiratory Medicine and Infectious Diseases, Bispebjerg Hospital, Copenhagen, Denmark;

32. Department of Respiratory Medicine and Allergy, Aarhus University Hospital, Aarhus City, Denmark;

33. Department of Respiratory Medicine, Copenhagen University, Hvidovre Hospital, Hvidovre, Denmark;

34. Department of Respiratory Medicine, Aalborg University Hospital, Aalborg, Denmark;

35. Allergy Clinic, Copenhagen University Hospital-Gentofte, Hellerup, Denmark;

36. Respiratory Research Unit, Bispebjerg University Hospital, Copenhagen, Denmark;

37. Center for Clinical Research and Prevention, Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark;

38. Department of Pulmonology, University of Tartu and Lung Clinic, Tartu University Hospital, Tartu, Estonia;

39. PhyMedExp, Université de Montpellier, Centre National de Recherche Scientifique, Institut National de la Santé et de la Recherche Médicale, Centre Hospitalier Universitaire de Montpellier, Montpellier, France;

40. Department of Respiratory Diseases, Bichat Hospital, Public Assistance-Hospitals of Paris North, Paris City University, Paris, France;

41. Department of Respiratory Medicine, Public Assistance-Hospitals of Paris North, Paris City University, Cochin Hospital and Institute (Unité Mixte de Recherche 1016), Paris, France;

42. 2nd Respiratory Medicine Department, National and Kapodistrian University of Athens Medical School, Attikon University Hospital, Athens, Greece;

43. Respiratory Medicine Department, University of Ioannina, Ioannina, Greece;

44. Division of Infection, Immunity & Respiratory Medicine, University of Manchester, Manchester, United Kingdom;

45. Allergy Department, 2nd Pediatric Clinic, University of Athens, Athens, Greece;

46. Pulmocare Research and Education Foundation, Pune, India;

47. Department of Medicine and

48. School of Medicine, Trinity College Dublin, Dublin, Ireland;

49. Clinical Research Centre, Beaumont Hospital, Dublin, Ireland;

50. Department of Respiratory Medicine, Royal College of Surgeons in Ireland, Dublin, Ireland;

51. Severe Asthma Network Italy, Milan, Italy;

52. Personalized Medicine, Asthma and Allergy, Istituto di Ricovero e Cura a Carattere Scientifico Humanitas Research Hospital, Rozzano, Italy;

53. Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy;

54. Department of Clinical and Biological Sciences, Severe Asthma and Rare Lung Disease Unit, San Luigi Gonzaga University Hospital, University of Turin, Turin, Italy;

55. Kindai University Hospital, Osakasayama, Japan;

56. Microbiology Department, College of Medicine, Kuwait University, Al-Rashed Allergy Center, Ministry of Health, Kuwait City, Kuwait;

57. Department of Allergy and Immunology, National Medical Center of Bajio, University of Guanajuato, Guanajuato, Mexico;

58. Division of Internal Medicine Asthma and Allergy, Medical University of Łódź, Łódź, Poland;

59. Center for Health Technology and Services Research (CINTESIS),

60. Health Research Network (RISE), and

61. Departamento de Medicina da Comunidade, Informação e Decisão em Saúde (MEDCIDS), Faculty of Medicine, University of Porto, Porto, Portugal;

62. Department of Pulmonology, King Fahad Medical City, Riyadh, Saudi Arabia;

63. Alfaisal University, Riyadh, Saudi Arabia;

64. Department of Respiratory and Critical Care Medicine, Singapore General Hospital, Singapore;

65. Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, South Korea;

66. Hospital Universitari Son Espases, Fundación Instituto de Investigación Sanitaria Islas Baleares–Ciberes, Mallorca, Spain;

67. Pneumology Service, Lucus Augusti University Hospital, Sergas (Galician Healthcare Service) Integrated Management Structure (EOXI) Lugo, Monforte e Cervo, Lugo, Spain;

68. School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan;

69. Department of Chest Medicine, Taipei Veterans General Hospital, Taipei, Taiwan;

70. Division of Pulmonary Medicine, Department of Internal Medicine, Shuang Ho Hospital, Taipei Medical University, New Taipei City, Taiwan;

71. Department of Medicine, National Taiwan University Cancer Center, Taipei, Taiwan;

72. Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine and

73. School of Medicine, College of Medicine, Department of Internal Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan;

74. Rashid Hospital, Dubai Health Authority, Dubai, United Arab Emirates;

75. College of Medicine, University of Sharjah, Sharjah, United Arab Emirates;

76. Guy’s Severe Asthma Centre, Guy’s Hospital, King’s College London, London, United Kingdom;

77. Centre for Public Health, School of Medicine, Dentistry and Biomedical Sciences and

78. Wellcome-Wolfson Institute for Experimental Medicine, Queen’s University Belfast, Belfast, United Kingdom;

79. Department of Respiratory Medicine, Barts Health National Hospital Service Trust, London, United Kingdom;

80. Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom;

81. Allergy Partners of Albuquerque, Albuquerque, New Mexico;

82. Division of Allergy and Clinical Immunology, Department of Medicine, and

83. Saint Joseph Hospital, National Jewish Health, Denver, Colorado;

84. Centre for Applied Health Economics, Griffith University, Brisbane, Australia;

85. Research Unit, Department of Respiratory Medicine and Infectious Diseases, Bispebjerg Hospital, Copenhagen, Denmark; and

86. Centre of Academic Primary Care, Division of Applied Health Sciences, University of Aberdeen, Aberdeen, United Kingdom

Funder

Optimum Patient Care Global

AstraZeneca Ltd

Publisher

American Thoracic Society

Subject

Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3